Charles Elder

A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination.

K. Jansen, W. Gruber, Mariano M Young, 2021, Vaccine.